Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 955-961

  Hou, X ^a   Wehrle, J ^c   Menge, W ^d   Ciccarelli, E ^a   Wess, J ^b   Mutschler, E ^c   Lambrecht, G ^c   Timmerman, H ^d   Waelbroeck, M ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c GOETHE UNIVERSITY   (Germany)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Affinity; Bs 6181; Coulombic interaction; Muscarinic receptors; Quaternary nitrogen; Uncharged muscarinic antagonist

Indexed keywords

3,3 DIMETHYLBUTYL BENZILATE; IMIDAZOLE; METHYLSCOPOLAMINE; MONOVALENT CATION; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 0029960329     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15287.x     Document Type: Article

References (24)

1. ASSELIN, J., WAELBROECK, M., ROBBERECHT, P., DE NEEF, P. & CHRISTOPHE, J. (1983). Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors. Biochem. J., 216, 11-19.
2. BANISTER, J. & WHITTAKER, V.P. (1951). Pharmacological activity of the carbon analogue of acetylcholine. Nature, 167, 605.
3. 3) muscarinic receptors in guinea-pig ileum assessed from the effects of the carbon analogue of 4-DAMP methiodide. Br. J. Pharmacol., 106, 819-822.
4. BARLOW, R.B. & CHAN, M. (1982). The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea-pig ileum and rat fundus strip. Br. J. Pharmacol., 77, 559-563.
5. BARLOW, R.B. & TUBBY, J.H. (1974). Actions of some esters of 3,3-dimethylbutan-1-ol (the carbon analogue of choline) on the guinea pig ileum. Br. J. Pharmacol., 51, 95-100.
6. BARLOW, R.B. & WINTER, E.A. (1981). Affinities of the protonated and non-protonated forms of hyoscine and hyoscine-N-oxide for muscarinic receptors of the guinea-pig ileum and a comparison of their size in solution with that of atropine. Br. J. Pharmacol., 72, 657-664.
7. BIRDSALL, N.J.M., BURGEN, A.S.V., HULME, E.C. & WELLS, J.W. (1979). The effects of ions on the binding of agonists and antagonists to muscarinic receptors. Br. J. Pharmacol., 67, 371-377.
8. BIRDSALL, N.J.M., CHAN, S.-C., EVELEIGH, P., HULME, E.C. & MILLER, K.W. (1989). The modes of binding of ligands to cardiac muscarinic receptors. Trends Pharmacol. Sci., 10, (Suppl.), 31-34.
9. BONNER, T.I. (1989). The molecular basis of muscarinic receptor diversity. Trends Neurosci., 12, 148-151.
10. BURGEN, A.S.V. (1965). The role of ionic interaction at the muscarinic receptor. Br. J. Pharmacol., 25, 4-17.
11. 50) which causes a 50 percent inhibition of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
12. EHLERT, F.J. & DELEN, F.M. (1990). Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats. Mol. Pharmacol., 38, 143-147.
13. FRASER, C.M., WANG, C.-D., ROBINSON, D.A., GOCAYNE, J.D. & VENTER, J.C. (1989). Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol., 36, 840-847.
14. FUNCKE, A.B.H., REKKER, R.F., ERNSTING, M.J.E., TERSTEEGE, H.M. & NAUTA, W.T. (1959). Untersuchungen über Spasmolytica; V. Benzilsäureester. Arzneim.-Forsch./Drug Res., 9, 573-576.
15. HOSEY, M.M. (1982). Regulation of antagonist binding to cardiac muscarinic receptors. Biochem. Biophys. Res. Commun., 107, 314-321.
16. HOSEY, M.M. (1983). Regulation of ligand binding to cardiac muscarinic receptors by ammonium ion and guanine nucleotides. Biochem. Biophys. Acta, 757, 119-127.
17. HULME, E.C. (1995). The role of charge interactions in muscarinic agonist binding, and receptor-response coupling. Life Sci., 56, 891-899.
18. HULME, E.C., BERRIE, C.P., BIRDSALL, N.J.M. & BURGEN, A.S.V. (1981). Two populations of binding sites for muscarinic antagonists in the rat heart. Eur. J. Pharmacol., 73, 137-142.
19. LEVINE, R.R. & BIRDSALL, N.J.M. (1989). Subtypes of muscarinic receptors IV. Trends Pharmacol. Sci., 10, (Suppl.).
20. a and subtype selectivity. Life Sci., 56, 1020.
21. i/Go-linked receptor and its allosteric regulation by monovalent cations. Life Sci., 52, 1899-1907.
22. WAELBROECK, M., CAMUS, J., TASTENOY, M., MUTSCHLER, E., STROHMANN, C., TACKE, R., LAMBRECHT, G. & CHRISTOPHE, J. (1991). Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects. Eur. J. Pharmacol., 206, 95-103.
23. WESS, J., GDULA, D. & BRANN, M.R. (1991). Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO J., 10, 3729-3734.
24. WESS, J., MAGGIO, R., PALMER, J.R. & VOGEL, Z. (1992). Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. J. Biol. Chem., 267, 19313-19319.